Alzheimer Disease, Early Onset Clinical Trial
Official title:
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
The purpose of this study is to generate preliminary data on the benefit of computerized cognitive training and Tai Chi- Qi Gong training in participants with Early-Onset Alzheimer's Disease. It is hypothesized that participants in the experimental training condition will perform better on outcomes related to cognition, functioning, and mood at follow-up compared to participants assigned to the active control condition.
This study aims to generate preliminary data regarding the efficacy of a combined cognitive-training and Tai Chi- Qi Gong exercise lifestyle intervention in participants diagnosed with Early-Onset Alzheimer's Disease (EOAD). Participants will complete a series of cognitive, functional, and mood assessments at a remotely-assessed baseline visit, and then be randomized into one of two conditions: (1) Computerized Cognitive Training + Tai Chi Exercise or (2) Active Control. Outcome measures will be repeated immediately Post-Treatment and at 6-months post-treatment Follow-Up. Specific Aim 1 will examine the feasibility of this lifestyle intervention and outcome assessments when applied to participants with EOAD. Specific Aim 2 will investigate if this lifestyle intervention improves short- and long-term cognition, functioning, and mood. Specific Aim 3 will be exploratory to assess whether individual differences in training or clinical/ demographic characteristics moderate the degree of benefit from this intervention; owing to sample size limitations in this feasibility study, focus of this latter aim will be on determining effect sizes and sample-size magnitude needed for future work. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03625401 -
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT05983575 -
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
|
Phase 3 | |
Completed |
NCT05989087 -
The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
|
||
Recruiting |
NCT06080659 -
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
|
N/A | |
Not yet recruiting |
NCT06099587 -
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
|
N/A | |
Not yet recruiting |
NCT05604183 -
Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT03514875 -
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
|
N/A | |
Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
Completed |
NCT03706885 -
Efavirenz for Patients With Alzheimer's Disease
|
Phase 1 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Not yet recruiting |
NCT05006599 -
SNIFF - 3-Week Aptar CPS Device
|
Phase 2 | |
Recruiting |
NCT02740634 -
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
|
N/A | |
Active, not recruiting |
NCT03069391 -
The Interactive Physical and Cognitive Exercise System
|
N/A | |
Recruiting |
NCT04701957 -
The Ketogenic Diet for Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06268886 -
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT04100889 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
|
||
Recruiting |
NCT04656860 -
Juice Plus Supplement Clinical Trial
|
N/A | |
Recruiting |
NCT05315895 -
The Dampness Syndrome of Chinese Medicine Cohort Study
|
||
Recruiting |
NCT04916964 -
Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial)
|
N/A | |
Recruiting |
NCT04804618 -
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
|